Fructose and vitamin C intake Do not influence risk for developing hypertension

Journal of the American Society of Nephrology

Volumn 20, Issue 4, 2009, Pages 863-871

  Forman, John P ^a,b,c   Choi, Hyon ^a,e   Curhan, Gary C ^a,b,c,d  

^a CHANNING LABORATORY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; FRUCTOSE; URIC ACID;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH PRACTITIONER; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; URIC ACID BLOOD LEVEL;

EID: 65249134375     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008050473     Document Type: Article

References (65)

1. Alper AB Jr, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL: Childhood uric acid predicts adult blood pressure: The Bogalusa Heart Study. Hypertension 45: 34-38, 2005
2. Forman JP, Choi H, Curhan GC: Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 18: 287-292, 2007
3. Hunt SC, Stephenson SH, Hopkins PN, Williams RR: Predictors of an increased risk of future hypertension in Utah: A screening analysis. Hypertension 17: 969-976, 1991
4. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, Mancini M, Trevisan M: Serum uric acid and hypertension: The Olivetti heart study. J Hum Hypertens 8: 677-681, 1994
5. Kahn HA, Medalie JH, Neufeld HN, Riss E, Goldbourt U: The incidence of hypertension and associated factors: The Israel ischemic heart disease study. Am Heart J 84: 171-182, 1972
6. Krishnan E, Kwoh CK, Schumacher HR, Kuller L: Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 49: 298-303, 2007
7. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42: 474-480, 2003
8. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, Wofford MR, Herrington DM: Serum uric acid predicts incident hypertension in a biethnic cohort: The atherosclerosis risk in communities study. Hypertension 48: 1037-1042, 2006
9. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K: Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 18: 523-530, 2003
10. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, Weiss ST, Litonjua AA: Uric acid and the development of hypertension: The normative aging study. Hypertension 48: 1031-1036, 2006
11. Selby JV, Friedman GD, Quesenberry CP Jr: Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 131: 1017-1027, 1990
12. Shankar A, Klein R, Klein BE, Nieto FJ: The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study. J Hum Hypertens 20: 937-945, 2006
13. Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS: Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 45: 28 -33, 2005
14. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K: Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens 19: 1209-1215, 2001
15. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ: A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897, 2002
16. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ: Hyperuricemia induces endothelial dysfunction. Kidney Int 67: 1739-1742, 2005
17. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38: 1101-1106, 2001
18. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ: A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290: F625-F631, 2006
19. Choi JW, Ford ES, Gao X, Choi HK: Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: The Third National Health and Nutrition Examination Survey. Arthritis Rheum 59: 109-116, 2008
20. Gao X, Chen H, Choi HK, Curhan GC, Schwarzschild MA, Ascherio A: Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol 167: 831-838, 2008
21. Gao X, Qi L, Qiao N, Choi HK, Curhan G, Tucker KL, Ascherio A: Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension 50: 306 -312, 2007
22. Gao X, Curhan GC, Forman JP, Ascherio A, Choi HK: Vitamin C intake and serum uric acid concentration in men. J Rheumatol 35: 1201-1207, 2008
23. Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, Miller ER 3rd: The effects of vitamin C supplementation on serum concentrations of uric acid: Results of a randomized controlled trial. Arthritis Rheum 52: 1843-1847, 2005
24. Choi HK, Curhan GC: Soft drinks, fructose consumption, and the risk of gout in men: A prospective cohort study. BMJ 336: 309 -312, 2008
25. Lyu LC, Hsu CY, Yeh CY, Lee MS, Huang SH, Chen CL: A case-control study of the association of diet and obesity with gout in Taiwan. Am J Clin Nutr 78: 690-701, 2003
26. Nakagawa T, Tuttle KR, Short RA, Johnson RJ: Hypothesis: Fructose- induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 1: 80-86, 2005
27. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF, Barnett AH: Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 27: 484-490, 1997
28. Scott GS, Cuzzocrea S, Genovese T, Koprowski H, Hooper DC: Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci U S A 102: 3483-3488, 2005
29. Waring WS, Adwani SH, Breukels O, Webb DJ, Maxwell SR: Hyper-uricaemia does not impair cardiovascular function in healthy adults. Heart 90: 155-159, 2004
30. Waring WS, McKnight JA, Webb DJ, Maxwell SR: Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes 55: 3127-3132, 2006
31. Paravicini TM, Touyz RM: Redox signaling in hypertension. Cardiovasc Res 71: 247-258, 2006
32. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD: Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35: 746-751, 2000
33. Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R: Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: Results from 2 placebo-controlled studies. Circulation 105: 2619-2624, 2002
34. El Solh AA, Saliba R, Bosinski T, Grant BJ, Berbary E, Miller N: Allopurinol improves endothelial function in sleep apnoea: A randomised controlled study. Eur Respir J 27: 997-1002, 2006
35. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD: Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106: 221-226, 2002
36. Guthikonda S, Sinkey C, Barenz T, Haynes WG: Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 107: 416-421, 2003
37. George J, Carr E, Davies J, Belch JJ, Struthers A: High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 114: 2508-2516, 2006
38. Choi HK, Mount DB, Reginato AM: Pathogenesis of gout. Ann Intern Med 143: 499-516, 2005
39. Fox IH, Palella TD, Kelley WN: Hyperuricemia: A marker for cell energy crisis. N Engl J Med 317: 111-112, 1987
40. Fox IH, Kelley WN: Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 21: 713-721, 1972
41. Raivio KO, Becker A, Meyer LJ, Greene ML, Nuki G, Seegmiller JE: Stimulation of human purine synthesis de novo by fructose infusion. Metabolism 24: 861-869, 1975
42. Gao X, Curhan G, Forman JP, Ascherio A, Choi HK: Vitamin C intake and serum uric acid concentration in men. J Rheumatol 35: 1853-1858, 2008
43. Berger L, Gerson CD, Yu TF: The effect of ascorbic acid on uric acid excretion with a commentary on the renal handling of ascorbic acid. Am J Med 62: 71-76, 1977
44. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H: Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417: 447-452, 2002
45. Thangaraju M, Ananth S, Martin PM, Roon P, Smith SB, Sterneck E, Prasad PD, Ganapathy V: c/ ebpdelta Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney. J Biol Chem 281: 26769 -26773, 2006
46. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD Jr: Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 45: 934-939, 2005
47. Chade AR, Rodriguez-Porcel M, Herrmann J, Krier JD, Zhu X, Lerman A, Lerman LO: Beneficial effects of antioxidant vitamins on the stenotic kidney. Hypertension 42: 605-612, 2003
48. McNally JS, Saxena A, Cai H, Dikalov S, Harrison DG: Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscler Thromb Vasc Biol 25: 1623-1628, 2005
49. Hassoun PM, Yu FS, Zulueta JJ, White AC, Lanzillo JJ: Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. Am J Physiol 268: L809-L817, 1995
50. Landmesser U, Spiekermann S, Preuss C, Sorrentino S, Fischer D, Manes C, Mueller M, Drexler H: Angiotensin II induces endothelial xanthine oxidase activation: Role for endothelial dysfunction in patients with coronary disease. Arterioscler Thromb Vasc Biol 27: 943-948, 2007
51. Falciani F, Ghezzi P, Terao M, Cazzaniga G, Garattini E: Interferons induce xanthine dehydrogenase gene expression in L929 cells. Biochem J 285: 1001-1008, 1992
52. Ghezzi P, Bianchi M, Mantovani A, Spreafico F, Salmona M: Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem Biophys Res Commun 119: 144-149, 1984
53. Heller R, Munscher-Paulig F, Grabner R, Till U: L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 274: 8254-8260, 1999
54. Beetens JR, Herman AG: Vitamin C increases the formation of prostacyclin by aortic rings from various species and neutralizes the inhibitory effect of 15-hydroperoxy-arachidonic acid. Br J Pharmacol 80: 249-254, 1983
55. Frei B, Stocker R, England L, Ames BN: Ascorbate: The most effective antioxidant in human blood plasma. Adv Exp Med Biol 264: 155-163, 1990
56. Colditz GA: The nurses' health study: A cohort of US women followed since 1976. J Am Med Womens Assoc 50: 40-44, 1995
57. Wolf AM, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Corsano KA, Rosner B, Kriska A, Willett WC: Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 23: 991-999, 1994
58. Colditz GA, Rimm EB, Giovannucci E, Stampfer MJ, Rosner B, Willett WC: A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol 67: 933-938, 1991
59. Willett WC: Nutritional Epidemiology, 2nd Ed., New York, Oxford University Press, 1998, pp 101-147
60. Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, Willett WC: Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 93: 790-796, 1993
61. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC: Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135: 1114 -1126, discussion 1127-1136, 1992
62. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE: Reproducibility and validity of a semi-quantitative food frequency questionnaire. Am J Epidemiol 122: 51-65, 1985
63. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC: Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1: 466-473, 1990
64. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE: Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123: 894-900, 1986
65. Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, Sacks F, Stampfer MJ: A prospective study of nutritional factors and hypertension among US men. Circulation 86: 1475-1484, 1992